
Get answers to your Chronic Myelogenous Leukemia questions by
e-mailing Dr. Rapoport.
Dr. Rapoport’s Bio | Q&A Archive
Imatinib (Gleevec) is the first line of therapy for all patients. Gleevec blocks the Philadelphia chromosome and is assosicated with very high rates of remission. Similar drugs are being developed.
Sometimes a chemotherapy medicine called hydroxyurea (Hydrea) is used temporarily to control the white blood cell count.
The only known cure for CMS is a bone marrow transplant or stem cell transplantation.
You should discuss your options in detail with your oncologist.
For additional information and resources, see cancer support group and leukemia support group .
Since the introduction of Gleevec, the outlook for patients with CMS has improved dramatically. Many patients can remain in remission for many years while on this drug.
Transplantation should be considered in all patients. Long-term cure after transplantation ranges from 60 - 80%.
Blast crisis can lead to complications of CML, including infection, bleeding, fatigue, unexplained fever, and kidney problems. Chemotherapy can have serious side effects, depending on the drugs used.
Call your health care provider if you have symptoms suggestive of CML or have been diagnosed with CML and develop a fever higher than 100°F, chills, sore throat, or cough.
|
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial process . A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch). |